Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni
Sci Rep. 2018-01-05; 8(1):
DOI: 10.1038/s41598-017-18750-8


Read on PubMed

---

Borroni B(1), Stanic J(2), Verpelli C(3), Mellone M(2), Bonomi E(4), Alberici A(4), Bernasconi P(5), Culotta L(3), Zianni E(2), Archetti S(6), Manes M(4), Gazzina S(4), Ghidoni R(7), Benussi L(7), Stuani C(8), Di Luca M(2), Sala C(3), Buratti E(8), Padovani A(4), Gardoni F(9).

Author information:
(1)Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
(2)Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
(3)CNR Institute of Neuroscience and Department of Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
(4)Neurology Unit, Centre for Neurodegenerative Disorders, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
(5)IRCCS Carlo Besta, Milan, Italy.
(6)III Laboratory of Analyses, Biotechnology Laboratory, Brescia Hospital, Brescia, Italy.
(7)Molecular Markers Laboratory, IRCCS Fatebenefratelli S. Giovanni di Dio, Brescia, Italy.
(8)International Centre for Genetic Engineering and Biotechnology-ICGEB, Trieste, Italy.
(9)Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy. .

Erratum for
Sci Rep. 2017 Jul 27;7(1):6723.

A correction to this article has been published and is linked from the HTML
version of this paper. The error has been fixed in the paper.

Know more about